Hangzhou Minsheng Healthcare301507.SZValuation Analysis

As of Oct 19, 2026, Hangzhou Minsheng Healthcare (301507.SZ) trades at a P/E of 53.00x, P/B of 2.89x, P/S of 4.71x, and a dividend yield of 1.14%.
Longitudinal percentile comparison: P/E sits at the 74th percentile over the trailing 10Y window (vs. 77th percentile over 3Y); P/B sits at the 27th percentile over the trailing 10Y window (vs. 28th percentile over 3Y); P/S sits at the 33rd percentile over the trailing 10Y window (vs. 34th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 62nd percentile within its industry and the 63rd percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 1.83%, ranking at the 86th percentile over the trailing 20Y window.
Notably, P/E and P/B aren't telling quite the same story, 47.1 points apart — worth checking the full percentile matrix on this page for the complete picture. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Of the 1.83% total shareholder yield, 1.14% is paid out as dividends and roughly 0.70% is implied to come from buybacks — both channels are meaningfully in play. Hangzhou Minsheng Healthcare operates in the Medicine sector. Data refreshes weekly and is for reference only, not investment advice.